Abstract
OBJECTIVE:
Extremely low birth weight (ELBW) infants are at risk for hypotension. Abnormal adrenal function may play a role in the pathogenesis of hypotension, and therefore, the administration of hydrocortisone (HC) may be an effective treatment for hypotension in some infants. However, the efficacy of prophylactic HC to prevent the use of vasopressors for a defined hypotensive state has not been studied. We conducted a randomized-controlled trial to determine the potential role on adrenal insufficiency in early neonatal hypotension and to determine the effectiveness of prophylactic HC in reducing treatment of hypotension in ELBW infants.
STUDY DESIGN:
Infants were assigned to receive either HC or placebo within the first 3 hours of life. Therapy was continued for 5 days. The presence of hypotension was based on an operational definition and treatment with vasopressors (VP) was standardized based on an a priori protocol.
RESULTS:
A total of 34 patients were enrolled. Baseline characteristics were similar between groups. Of the HC group 25% received VP at 24 hours of age compared to 44% of the placebo group. On day of life 2, only 7% of the HC group received VP compared to 39% of the placebo group (p<0.05).
CONCLUSION:
Prophylactic treatment with HC reduces the incidence of hypotension, defined by treatment with VP, among ELBW infants during the first 2 days of life. However, the mounting evidence that prophylactic administration of glucocorticoids in the first days of life is harmful to ELBW infants makes HC prophylaxis unwise until the efficacy of treatment relative to safety can be clearly established.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gill AB, Weindling AM . Randomized controlled trial of plasma protein fraction versus dopamine in hypotensive very low birthweight infants. Arch Dis Child 1993;69:284–287.
Al-Aveel I, Pursley DM, Rubin LP, Shah B, Weisberger S, Richardson DK . Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol 2001;21:272–278.
Watkins AMC, West CR, Cooke RWI . Blood pressure and cerebral haemorrhage and ischaemia in very low birth weight infants. Early Hum Dev 1989;19:103–110.
Goldstein RF, Thompson RJ, Oehler JM, Brazy JE . Influence of acidosis, hypoxemia, and hypotension on neurodevelopmental outcomes in very low birth weight infants. Pediatrics 1995;95:238–243.
Zhang J, Penny DJ, Kim NS, Yu VY, Smolick JJ . Mechanisms of blood pressure increases induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fetal Neonatal Ed 1999;81:F99–F104.
Helbock HJ, Insoft RM, Conte FA . Glucocorticoid-responsive hypotension in extremely low birth weight newborns. Pediatrics 1993;92:715–717.
Ward RM, Kimura RE, Rich-Denson C . Addisonian crisis in extremely premature neonates. Clin Res 1991;39:11A.
Watterberg KL, Scott SM . Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics 1995;95:120–125.
Hanna CE, Jett PL, Laird MR, Mandel SH, LaFranchi SH, Reynolds JW . Corticosteroid binding globulin, total serum cortisol, and stress in extremely low-birth-weight infants. Am J Perinatol 1997;14:201–204.
Fauser A, Pohlandt F, Bartmann P, Gortner L . Rapid increase of blood pressure in extremely low birth weight infants after a single dose of dexamethasone. Eur J Pediatr 1993;152:354–356.
Gaissmaier RE, Poblandt F . Single-dose dexamethasone treatment of hypotension in preterm infants. J Pediatr 1999;134:701–705.
Tantivit P, Subramanian N, Garg M, Ramanathan R, deLemos RA . Low serum cortisol in term newborns with refractory hypotension. J Perinatol 1999;19:352–357.
O’Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-control trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilatory dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 1999;104:15–21.
Gordon PV, Young ML, Marshall DD . Focal small bowel perforation: an adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants. J Perinatol 2001;21:1–5.
Stoll BJ, Temprosa M, Tyson JE, et al. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics 1999;104:pe63. http://www.pediatrics.org/cgi/content/full/104/5/e63.
Hanna CB, Gilhooly JT, Reynolds JW . Hydrocortisone replacement in extremely premature infants with cortisol insufficiency. Clin Res 1989;37:180A.
Ng PC, Lam CWK, Fok TF, et al. Refractory hypotension in preterm infants with adrenocortical insufficiency. Arch Dis Child Fetal Neonatal Ed 2001;84:F122–F124.
Seri I, Tan R, Evans J . Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics 2001;107:1070–1074.
Young TE, Mangum OB, editors. Neofax: A Manual of Drugs Used in Neonatal Care. Raleigh, NC: Acorn Publishing; 1999. pp. 182–183.
Kitterman JA, Phibbs RH, Tooley WH . Aortic blood pressure in normal newborn infants during the first 12 hours of life. Pediatrics 1969;44:959–968.
Versmold HT, Kitterman JA, Phibbs RH, Gregory GA, Tooley WH . Aortic blood pressure during the first 12 hours of life in infants with birth weight 610 to 4,220 grams. Pediatrics 1981;67:607–613.
The International Neonatal Network. The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 1993;342:193–198.
Papile L, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 grams. J Pediatr 1978;92:529–534.
Calvert SA, Hoskins EM, Fong KW, Forsyth SC . Periventricular leukomalacia; ultrasonic diagnosis and neurologic outcome. Acta Paediatr Scand 1986;75:489–496.
Winter JSD . Fetal and neonatal adrenocortical physiology. In: Poplin RA, Fox WW, editors. Fetal and Neonatal Physiology. Philadelphia, PA: WB Saunders; 1998. pp. 2447–2459.
Hanna CE, Jett PL, Laird MR, Mandel SH, LaFranchi SH, Reynolds TW . Corticosteroid binding globulin, total serum cortisol, and stress in extremely low birth weight infants. Am J Perinatol 1997;14:201–204.
Jett PL, Samuels MH, McDaniel PA, et al. Variability of plasma cortisol levels in extremely low birth weight infants. J Clin Endocrinol Metab 1997;82:2921–2925.
Engle WD . Blood pressure in the very low birth weight neonate. Early Hum Dev 2001;62:97–130.
Seri I, Evans J . Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr 2001;13:116–123.
Nuntnarumit P, Yang W, Bada-Ellzey HS . Blood pressure measurements in the newborn. Clin Perinatol 1999;26:981–996.
Lee J, Rajadurai VS, Tan KW . Blood pressure standards for very low birth-weight infants during the first day of life. Arch Dis Child Fetal Neonatal Ed 1999;81:F168–F170.
Scott SM, Watterberg KL . Effect of gestational age, postnatal age, and illness on plasma cortisol concentrations in premature infants. Pediatr Res 1995;37:112–116.
Korte C, Styne D, Merritt TA, Mayes D, Wertz A, Helbock HJ . Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J Pediatr 1996;128:257–263.
Heckmann M, Wudy SA, Haack D, Pohlandt F . Serum cortisol concentrations in ill preterm infants less than 30 weeks gestational age. Acta Paediatr 2000;89:1098–1103.
Bourchier D, Weston PJ . Randomized trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants. Arch Dis Child 1997;76:F174–F178.
Merz U, Pfaffle R, Peschgens Th, Hornchen H . The hypothalamic–pituitary–adrenal axis in preterm infants weighing <1250 g: association with perinatal data and chronic lung disease. Acta Paediatr 1998;87:313–317.
Heckmann M, Wudy SA, Haack D, Pohlandt F . Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal Ed 1999;81:F171–F174.
Jazayeri A, Meyer III WJ . Glucocorticoid modulation of β-adrenergic receptors of cultured rat arterial smooth muscle cells. Hypertension 1988;12:393–398.
Botas CM, Kurlat I, Young SM, Sola A . Disseminated candidal infections and intravenous hydrocortisone in preterm infants. Pediatrics 1995;95:883–887.
Gordon PV, Marshall DD, Stiles AD, Price WA . The clinical, morphologic, and molecular changes in the ileum associated with early postnatal dexamethasone administration: from the baby's bowel to the researcher's bench. Mol Genet Metab 2001;72:92–103.
Garland JS, Alex CP, Pauly TH, et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 1999;104:91–99.
Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001;344:95–101.
Karlsson R, Kallio J, Toppari J, Scheinin M, Kero P . Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants. Horm Res 2000;53:170–176.
Ng PC, Wong GWK, Lam CWK, et al. Pituitary–adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids. J Clin Endocrinol Metab 1997;82:3548–3552.
Acknowledgements
This work was supported by Forest Pharmaceuticals, Inc.; a special dispensation grant to support collaborative clinical research by neonatal fellows at the University of North Carolina, Chapel Hill.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Efird, M., Heerens, A., Gordon, P. et al. A Randomized-Controlled Trial of Prophylactic Hydrocortisone Supplementation for the Prevention of Hypotension in Extremely Low Birth Weight Infants. J Perinatol 25, 119–124 (2005). https://doi.org/10.1038/sj.jp.7211193
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211193
This article is cited by
-
Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis
Cancer Cell International (2022)
-
Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis
European Journal of Pediatrics (2019)
-
Association between plasma cortisol and death or vasopressor refractory hypotension in preterm neonates: a prospective, cohort study
Journal of Perinatology (2018)
-
An evaluation of hydrocortisone dosing for neonatal refractory hypotension
Journal of Perinatology (2017)
-
Adding Hydrocortisone as 1st Line of Inotropic Treatment for Hypotension in Very Low Birth Weight Infants
The Indian Journal of Pediatrics (2014)